WVE · ISSUER CIK 1631574
Wave Life Sciences, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 8 Wave Life Sciences, Inc. insiders reported $0.00 of open-market purchases and $135K of sales on SEC Form 4.
↗8 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 4 of 4 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$135KInsider selling
−$135KNet open-market
Oct 7, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 202621:06 | Oct 5, 2026 | WVE | Director, 10% Owner · +3 joint | A · Grant | — | +10,700 | 39,515 | +37% | — | ||
| Oct 7, 202621:00 | Oct 5, 2026 | WVE | Director | A · Grant | — | +10,700 | 200,917 | +6% | — | ||
| Oct 7, 202621:00 | Oct 5, 2026 | WVE | Director | A · Grant | — | +10,700 | 35,668 | +43% | — | ||
| Oct 7, 202621:00 | Oct 5, 2026 | WVE | Director | A · Grant | — | +10,700 | 30,779 | +53% | — | ||
| Oct 7, 202621:00 | Oct 5, 2026 | WVE | Director | A · Grant | — | +10,700 | 39,515 | +37% | — | ||
| Oct 7, 202621:00 | Oct 5, 2026 | WVE | Director | A · Grant | — | +10,700 | 10,700 | New | — | ||
| Oct 7, 202621:00 | Oct 5, 2026 | WVE | Director | A · Grant | — | +10,700 | 55,630 | +24% | — | ||
| Oct 7, 202621:00 | Oct 5, 2026 | WVE | Director | A · Grant | — | +10,700 | 23,400 | +84% | — | ||
| Aug 13, 202621:00 | Aug 11, 2026 | WVE | Director | S · Sell10b5-1 | $6.01 | −7,000 | 44,930 | -13% | −$42K | ||
| Aug 13, 202621:00 | Aug 11, 2026 | WVE | Director | M · Exercise10b5-1 | $5.97 | +7,000 | 51,930 | +16% | $42K | ||
| Aug 13, 202621:00 | Aug 12, 2026 | WVE | Director | S · Sell10b5-1 | $5.29 | −12,700 | 0 | -100% | −$67K | ||
| Aug 13, 202621:00 | Aug 11, 2026 | WVE | Director | S · Sell10b5-1 | $6.01 | −3,864 | 20,079 | -16% | −$23K | ||
| Aug 13, 202621:00 | Aug 11, 2026 | WVE | Director | S · Sell10b5-1 | $6.01 | −432 | 24,968 | -2% | −$3K |